These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 22422317)

  • 1. Generation of induced pluripotent stem cells from a small amount of human peripheral blood using a combination of activated T cells and Sendai virus.
    Seki T; Yuasa S; Fukuda K
    Nat Protoc; 2012 Mar; 7(4):718-28. PubMed ID: 22422317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34
    Okumura T; Horie Y; Lai CY; Lin HT; Shoda H; Natsumoto B; Fujio K; Kumaki E; Okano T; Ono S; Tanita K; Morio T; Kanegane H; Hasegawa H; Mizoguchi F; Kawahata K; Kohsaka H; Moritake H; Nunoi H; Waki H; Tamaru SI; Sasako T; Yamauchi T; Kadowaki T; Tanaka H; Kitanaka S; Nishimura K; Ohtaka M; Nakanishi M; Otsu M
    Stem Cell Res Ther; 2019 Jun; 10(1):185. PubMed ID: 31234949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells.
    Seki T; Yuasa S; Oda M; Egashira T; Yae K; Kusumoto D; Nakata H; Tohyama S; Hashimoto H; Kodaira M; Okada Y; Seimiya H; Fusaki N; Hasegawa M; Fukuda K
    Cell Stem Cell; 2010 Jul; 7(1):11-4. PubMed ID: 20621043
    [No Abstract]   [Full Text] [Related]  

  • 4. Rapid and Efficient Generation of Transgene-Free iPSC from a Small Volume of Cryopreserved Blood.
    Zhou H; Martinez H; Sun B; Li A; Zimmer M; Katsanis N; Davis EE; Kurtzberg J; Lipnick S; Noggle S; Rao M; Chang S
    Stem Cell Rev Rep; 2015 Aug; 11(4):652-65. PubMed ID: 25951995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient Generation of Non-Integration and Feeder-Free Induced Pluripotent Stem Cells from Human Peripheral Blood Cells by Sendai Virus.
    Ye H; Wang Q
    Cell Physiol Biochem; 2018; 50(4):1318-1331. PubMed ID: 30355953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of Human Induced Pluripotent Stem Cells from Peripheral Blood Mononuclear Cells Using Sendai Virus.
    Soares FA; Pedersen RA; Vallier L
    Methods Mol Biol; 2016; 1357():23-31. PubMed ID: 25687300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
    Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
    Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reprogramming human B cells into induced pluripotent stem cells and its enhancement by C/EBPα.
    Bueno C; Sardina JL; Di Stefano B; Romero-Moya D; Muñoz-López A; Ariza L; Chillón MC; Balanzategui A; Castaño J; Herreros A; Fraga MF; Fernández A; Granada I; Quintana-Bustamante O; Segovia JC; Nishimura K; Ohtaka M; Nakanishi M; Graf T; Menendez P
    Leukemia; 2016 Mar; 30(3):674-82. PubMed ID: 26500142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induced pluripotent stem cells (iPSCs) derived from frontotemporal dementia patient's peripheral blood mononuclear cells.
    Lee HK; Morin P; Wells J; Hanlon EB; Xia W
    Stem Cell Res; 2015 Sep; 15(2):325-7. PubMed ID: 26246272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of Human iPSCs by Episomal Reprogramming of Skin Fibroblasts and Peripheral Blood Mononuclear Cells.
    Febbraro F; Chen M; Denham M
    Methods Mol Biol; 2021; 2239():135-151. PubMed ID: 33226617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of human induced pluripotent stem cells from cord blood cells.
    Nishishita N; Takenaka C; Fusaki N; Kawamata S
    J Stem Cells; 2011; 6(3):101-8. PubMed ID: 23264996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation and characterization of a human iPSC line (UAMi005-A) from a patient with nonketotic hyperglycinemia due to mutations in the GLDC gene.
    Arribas-Carreira L; Bravo-Alonso I; López-Márquez A; Alonso-Barroso E; Briso-Montiano Á; Arroyo I; Ugarte M; Pérez B; Pérez-Cerdá C; Rodríguez-Pombo P; Richard E
    Stem Cell Res; 2019 Aug; 39():101503. PubMed ID: 31349202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
    Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
    J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of transgene-free human induced pluripotent stem cells with an excisable single polycistronic vector.
    Papapetrou EP; Sadelain M
    Nat Protoc; 2011 Aug; 6(9):1251-73. PubMed ID: 21886095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Efficacy and Safety of Sendai Viral Reprograming of Mouse Primary Cells Using Human Vectors.
    Tarnawski L; Eugster E; DeCamp L; Jovinge S
    Cell Reprogram; 2019 Apr; 21(2):78-88. PubMed ID: 30969880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of two human iPSC lines (MDCUi001-A and MDCUi001-B) from dermal fibroblasts of a Thai patient with X-linked osteogenesis imperfecta using integration-free Sendai virus.
    Tongkobpetch S; Rungsiwiwut R; Pruksananonda K; Suphapeetiporn K; Shotelersuk V
    Stem Cell Res; 2019 Aug; 39():101493. PubMed ID: 31326747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a synthetic xeno-free culture substrate for induced pluripotent stem cell induction and retinal differentiation.
    Tucker BA; Anfinson KR; Mullins RF; Stone EM; Young MJ
    Stem Cells Transl Med; 2013 Jan; 2(1):16-24. PubMed ID: 23283489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of an integration-free induced pluripotent stem cell line (CSC-43) from a patient with sporadic Parkinson's disease.
    Marote A; Pomeshchik Y; Goldwurm S; Collin A; Lamas NJ; Pinto L; Salgado AJ; Roybon L
    Stem Cell Res; 2018 Mar; 27():82-85. PubMed ID: 29334630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human transgene-free amniotic-fluid-derived induced pluripotent stem cells for autologous cell therapy.
    Jiang G; Di Bernardo J; Maiden MM; Villa-Diaz LG; Mabrouk OS; Krebsbach PH; O'Shea KS; Kunisaki SM
    Stem Cells Dev; 2014 Nov; 23(21):2613-25. PubMed ID: 25014361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration-free induced pluripotent stem cells derived from retinitis pigmentosa patient for disease modeling.
    Jin ZB; Okamoto S; Xiang P; Takahashi M
    Stem Cells Transl Med; 2012 Jun; 1(6):503-9. PubMed ID: 23197854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.